Levy-like movement patterns of metastatic cancer cells revealed in microfabricated systems and implicated in vivo by Huda, Sabil et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/197691
 
 
 
Please be advised that this information was generated on 2019-06-02 and may be subject to
change.
ARTICLE
Lévy-like movement patterns of metastatic cancer
cells revealed in microfabricated systems and
implicated in vivo
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Gary Wilk1, Masatomo Iwasa7, Fateme S. Emami1, Jakub W. Narojczyk4, Michal Banaszak8,
Siowling Soh1, Didzis Pilans1, Amir Vahid1, Monika Makurath1, Peter Friedl2,3,9, Gary G. Borisy10,
Kristiana Kandere-Grzybowska5,6 & Bartosz A. Grzybowski 5,11
Metastatic cancer cells differ from their non-metastatic counterparts not only in terms of
molecular composition and genetics, but also by the very strategy they employ for loco-
motion. Here, we analyzed large-scale statistics for cells migrating on linear microtracks to
show that metastatic cancer cells follow a qualitatively different movement strategy than
their non-invasive counterparts. The trajectories of metastatic cells display clusters of small
steps that are interspersed with long “ﬂights”. Such movements are characterized by heavy-
tailed, truncated power law distributions of persistence times and are consistent with the
Lévy walks that are also often employed by animal predators searching for scarce prey or
food sources. In contrast, non-metastatic cancerous cells perform simple diffusive move-
ments. These ﬁndings are supported by preliminary experiments with cancer cells migrating
away from primary tumors in vivo. The use of chemical inhibitors targeting actin-binding
proteins allows for “reprogramming” the Lévy walks into either diffusive or ballistic
movements.
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The motility of mammalian cells has been studied fordecades1,2, and trajectories of cell movements have beenquantiﬁed in various ways. Early models of cell motility
were founded on the classic Langevin equation and described the
movements of adherent cells3–5 (for description of smaller, faster,
and weakly-adherent immune cells, see ref. 6,7) as an
Ornstein–Uhlenbeck (OU) process,8 such that the cell’s mean
square displacement, < x(t)2 > , is expressed as 2nD (t – P (1 – exp
(-t/P)), where n is the dimensionality of the system, D is the
diffusion coefﬁcient, and P is the so-called persistence time. This
model predicts Gaussian distribution of velocities that are expo-
nentially correlated in time, leading to directional persistence on
short time scales (t < P)9. On long time scales (t » P), the model is
reduced to a random walk and predicts uniform distribution of
turning angles. This formalism has been successfully applied to
describe the motions—coined persistent random walks (PRWs)—
of ﬁbroblasts, lung epithelial cells, and microvessel endothelial
cells3–5. In addition, due to apparent directional persistence,
animal as well as cellular movements have frequently been
described as “correlated random walks” (CRWs)7,10,11. In
CRWs1, the step sizes/times are drawn from the Gaussian or
other exponentially decaying distribution, and the direction of the
preceding step inﬂuences the direction of the next step. Overall,
both PRW and CRW models predict that cell movements are
ballistic (i.e., persistent in direction or < x2 > ~ tα with α= 2) at
short times and diffusive (α= 1) at long time scales. Lévy walks—
recently detected in T cells6—are different because they are
superdiffusive12 (i.e., < x2 > ~ tα with 1 < α < 2) at all times and
are composed of sequences of many short steps interspersed with
longer "ﬂights". This pattern is conserved across all scales, in
effect giving rise to fractal patterns with no characteristic scale13.
Mathematically, Lévy walks14,15 are characterized by non-Gaus-
sian, heavy-tailed, power law distribution of persistence times/
step sizes, such that P(t) ~ t -μ, where t is persistence time/step size
or time/distance it takes to move one step between the turns and
μ is power law (Lévy) exponent with 1 < μ < 3. In the absence of a
characteristic scale, the overall length of a Lévy walk is deter-
mined by the longest step and the step-length variance grows over
time, though it remains ﬁnite even when unbounded by biological
and environmental considerations. Most biological systems are
bounded/limited (e.g., cell trajectories are limited by cell cycle and
environmental conditions), resulting in truncation of the power
law tail14,16–18, which introduces characteristic scale to the
movement pattern. However, variability around the characteristic
scale is very large and self-similar, which is in sharp contrast to
other ﬁnite-scale movement patterns. Lévy-like movement pat-
terns have been observed in movements of a number of multi-
cellular animals17–25 and humans26,27, found in trace fossil
trails17, and recently also in T cells searching for parasite-infected
cells6, swarming bacteria28,29, and even molecular motors within
cells16. The observation of Lévy walks has been attributed to the
execution of an optimal search strategy for sparsely and randomly
distributed resources/target sites30–33, though this interpretation
has not been generally accepted13,34.
With the general applicability of each of these models still being
debated,9,35 one outstanding and important question concerns the
movement patterns of non-metastatic versus metastatic cancer cells.
Although the latter are known to have higher migration velocity
and, in some cases, increased directional persistence36–39, it remains
unclear whether increased metastatic potential is reﬂected by a
qualitative change in the overall strategy of cell locomotion.
In this work, we address this question with a material system of
micropatterned lines10,40 on which the cells perform one-
dimensional motions which (i) have been shown41 to mimic
the motility of cells migrating in 3D better than commonly used
planar substrates and (ii) are observed in metastasizing tumor
cells in vivo, attaching preferentially to and moving along linear
ﬁbers (e.g., collagen ﬁbers36) or along preexisting linear peri-
muscular or perineural “microchannels”42,43. Importantly, the
“microtracks” we use enable unambiguous determination of
persistence times—as the times that cells move “to the left” or “to
the right” before reverting their direction of motion44—and col-
lection of large numbers of data points such that even the low-
probability events are captured. Statistical analysis of such data
then reveals that while non-metastatic cancerous cells are simple
diffusive movers, the metastatic ones not only move in a super-
diffusive fashion (which has been shown before45,46 but not in the
context of metastatic cells), but also display movement patterns
consistent with Lévy walks1,47. Signiﬁcantly, we also detect Lévy
walks of metastatic cells migrating in preliminary in vivo studies,
in which we used state-of-the-art intravital multiphoton micro-
scopy to resolve trajectories of individual cancer cells migrating
away from animal-implanted tumors. While the generality of the
observed trends certainly merits additional studies (especially
in vivo), the results we describe pose some intriguing questions as
to why the invasive cancerous cells have developed a movement
strategy that is frequently observed in multicellular animal pre-
dators and hunters17–25 (as well as killer/effector T cells6
searching for rare target cells) and, as mentioned above, is
thought to correspond to an optimal search strategy for sparsely
and randomly distributed resources/target sites30–33 (but see
also,34). In this context, toward the end of the paper, we describe
experiments in which RNA interference and chemical inhibition
of actin-binding proteins can change the Lévy walking phenotype
of metastatic “predators” into either unidirectional, ballistic
motions, or into diffusive migrations characterizing benign or
non-invasive cancerous cells.
Results
Lévy walks of metastatic cancer cells revealed on linear
microtracks. Most of the in vitro experiments were performed on
linear microtracks etched in gold-on-glass substrates using the so-
called Wet Etching technique40,48,49 (Fig. 1a; for all fabrication
details, see Supplementary Methods/Supplementary Note 1). The
gold regions were protected with self-assembled monolayers,
SAMs50,51, of oligo (ethylene glycol)-terminated alkyl thiols (HS
(CH2)11(OCH2CH2)6OH; EG6 (ProChimia Surfaces, Gdansk,
Poland: www.prochimia.com) known to prevent cell adhesion.
The unprotected glass lines were covered with either Laminin
(Sigma-Aldrich, cat. # L2020) or Laminin 5 (LN 5; extracted from
804G cells in crude form, as previously described52)—these
extracellular matrix substrates were chosen because of their
motility-promoting characteristics (vs. more adhesive ﬁbronectin)
and because they are routinely used as physiologically relevant
substrates of choice for the respective cell lines.
When the cells were applied (at plating density of ~10,000
cells/cm2) onto microstructured substrates presenting arrays of
20-μm-wide linear tracks, they localized exclusively onto these
tracks, spread, and, to a good approximation, displayed one-
dimensional motions (Fig. 1b). We compared and contrasted
motions of six types of cells from three cancers (Fig. 2;
Supplementary Figure 1): non-metastatic PC-3 and metastatic
PC-3M53 prostate cancer cells; non-metastatic MCF-7 and
metastatic MDA-MB-23138 breast cancer cells; and non-
metastatic B16-F0 and metastatic B16-F154 mouse melanoma
cells. Regarding the cell line choices, we note that for B16 and PC
lines, cells are termed metastatic versus non-metastatic based on,
respectively, their low and high metastatic potentials53,54. For
breast cancer lines, the MCF-7 cell line retains several
characteristics of differentiated mammary epithelium and repre-
sents a poorly invasive luminal subtype of breast cancer, whereas
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the MDA-MB-231 line represents a highly invasive basal subtype
of breast cancer55.
Using an automated image acquisition and analysis protocol
developed in-house, we were able to monitor cell motions for up
to 16 h and collect robust statistics with n= 17–69 different cells
and ~5120–20,800 time points per every cell type studied (see
Table 1 legend). Only tracks housing one cell (~60% of all tracks
at the plating density used) were analyzed to eliminate any
potential artifacts due to cell–cell collisions (see Supplementary
Note 1 for comment on cell collisions). The typical trajectories of
cells on the microtracks shown in Fig. 1c, Fig. 2a, b, and
Supplementary Figure 1 are characteristic of, respectively,
metastatic and non-metastatic cells (see Supplementary Movies 1
vs. 2, 3 vs. 4 and 5 vs. 6; also Supplementary Movies 13–15).
To quantify these cell trajectories and the dynamics of cell
motions, we ﬁrst plotted cells’ mean square displacements,
x2h i ¼ xðt þ t0Þ  xðt0Þ½ 2
 
, versus time, t, where :::h i denotes
a combined average over all starting times t0 and cell paths (see
refs. 12,45). When plotted on a log–log scale, these dependencies
give straight lines corresponding to x2h i ¼ tα scaling, with the
slope of the lines being the exponent α. From statistical physics, it
is well known12 that α= 1 indicates diffusive motion, values 1 < α
<2 correspond to superdiffusion, and α= 2 is characteristic of
ballistic motion (e.g., unidirectional motion without turns). As
evidenced by the plots in Fig. 2c, all non-metastatic cells we
studied move diffusively (α ~ 1) while their highly metastatic
variants move in a superdiffusive fashion (α ~ 1.5–1.6). These
characteristics are conserved over the entire time domain and not
only short term (as CRW or PRWs).
Long-term superdiffusive behavior is sometimes found in
systems performing Lévy walks,47 which are a sub-class of
random walks and are characterized by periods of small steps
interspersed with long but infrequent unidirectional excur-
sions. Typical cell trajectories such as those shown in Fig. 1c
and Fig. 2a (see also Supplementary Figure 1–3 and Supplemen-
tary Movies 1, 3, 5, and 13–15) suggest that the metastatic MDA-
MB-231, PC-3M, and B16-F1 cells might indeed be performing
Lévy walks. This hypothesis can be mathematically veriﬁed by the
analysis of cells' cumulative frequency distributions, CFDs, of
persistence times (i.e., the persistence time is deﬁned as the time
that cell moves persistently in a given direction12). When such
distributions are plotted on a log–log scale, it is evident that the
CFDs corresponding to metastatic cells are more heavy-tailed
than CFDs corresponding to non-metastatic ones (Fig. 2 d–f).
However, extreme care must be taken when assigning such trends
to a speciﬁc functional form, especially given recent ﬁndings56,57
that the use of inaccurate statistical methods has led to an
incorrect assignment of the search/movement patterns as Lévy
ﬂights in a number of studies. Accordingly, we followed the
rigorous procedure developed by Edwards et al.57,58 to test power
law distributions using the likelihood and Akaike weights (which
measure an appropriateness of a given ﬁt57,58) and tested multiple
alternative competing models (see also Supplementary Notes 1
and 2, and Supplementary Tables 1, 2) as detailed by Clauset
et al56. In addition to power law and exponential models, we also
considered heavy-tailed log-normal (observed in motions of
T cells within lymph nodes7), heavy-tailed stretched exponen-
tial56, as well as a truncated power law59 (in which power law tail
of Lévy walk is truncated).
In particular, the truncated power law was considered because
data collection time was limited for both short and long times. The
short time limitation at ~3–5min was due to relatively large cell sizes
and small speeds (respectively, ~20–40 μm and ~0.25–2 μm/min for
metastatic cells vs. ~ 7 μm and ~ 6–12 μm/min for T cells studied in
ref. 6), making it difﬁcult to (1) distinguish their translocation from
just the membrane dynamics, and (2) limit the photo-damage
imposed to cells by laser/light exposure. The long time limitation
was due to the cells dividing (e.g., ~30 h for MDA-MB-231). It is
therefore impossible to obtain single-cell data spanning the desirable
two decades of persistence times and enhancing statistics of low-
probability, long cellular excursions in the power law’s tail60.
Instead, we (akin to others9,35,46) have analyzed persistence-time
distributions over the populations of single cells (see also
Supplementary Figure 4 for single-cell analysis). This being said,
to capture as many long excursions as possible, in some experiments
we managed to record individual cellular trajectories for up to 40 h
(if cells divided during observation time, they were tracked only up
to division event) and total displacements up to 1000 μm (see
Supplementary Figures 2, 5, Supplementary Table 3, and Supple-
mentary Movies 13–15).
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Fig. 1 Trajectories of cancer cell motions on linear microtracks. a Scheme of
substrate fabrication using the Wet Etching technique40, 48, 49. b Optical
micrographs showing a cell migrating on a microtrack (scale bar= 20 µm).
The cell moves along the etched, optically transparent microtrack, and not
across cell-adhesion-resistant dark regions. The deﬁnition of step
persistence length/time is the distance/time the cell travels in one
direction before it reverts the direction of motion. The arrows labeled L1, L2,
and L3 indicate three consecutive “steps” of the cell (here, to the right, to
the left, and to the right again). c A representative trajectory of a metastatic
cell comprised of clusters of “small” steps (shown in gray) interspersed
with “large” steps (color denotes elapsed time and each long step is in
different color) is characteristic of a Lévy walk (see also Supplementary
Figure 2 for long-term trajectories). Scale bar is 100 μm for Lévy trajectory
and 20 μm for the inset. This can be contrasted with a trajectory of a non-
metastatic cell exhibiting diffusive motion (all steps are small and shown in
gray, scale bar is 20 μm). Note that while cell motions in experiments are in
1D (along microtracks), the vertical axis in the trajectories shown here
corresponds to time (from top to bottom). Total length of each trajectory is
960min with each point 3 min apart. See also Supplementary Movies 1–6.
The distinction between “small” and “large” steps is best appreciated by
viewing long-term Supplementary Movies 13–15
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The results summarized in Fig. 2d–f and Table 1 demonstrate
that only the metastatic cells (PC-3M, MDA-MB-231, B16-F1)
exhibit log–log distributions of persistence times that can be
assigned as Lévy walks. While the cumulative frequency
distribution, CFD, plots might “appear” to ﬁt a simple power
law (PðtÞ ¼ ðμ 1Þaμ1tμ; t  a, where ðμ 1Þaμ1 is the
normalization constant and parameter a determines the time at
which a power law ﬁt is appropriate; a values are listed in
Table 1), detailed maximum likelihood and Akaike-weight
analyses evidence that a more appropriate ﬁt is a truncated
power law, P tð Þ ¼ μ1a1μb1μ
 
tμ, where b is an upper truncation
parameter corresponding to the maximal point in each dataset.
Importantly, the values of exponents µ in these ﬁts are below 3,
corresponding to Lévy walks. Moreover, such analyses conﬁrm
that the truncated power law ﬁt is superior to all alternative
models considered (Fig. 2d–f, Table 1, see also Supplementary
Figure 5 for CFDs and model ﬁts; Supplementary Figure 6 for
evaluation of log-normal distribution; Supplementary Tables 1
Table 1 Statistical analysis of cancer cell movements on 1D microtracks
Cell type MSD (α) MLE for μ MLE for μ Akaike weights
Power law Truncated power law TP P LN SE E
PC-3M 1.58 ± 0.02 2.39 ± 0.2, a= 18 2.22 ± 0.16, a= 9 0.98 < 0.01 < 0.01 < 0.01 < 0.01
MDA-MB-231 1.54 ± 0.01 2.58 ± 0.4, a= 12 2.49 ± 0.07, a= 6 > 0.99 < 0.01 < 0.01 < 0.01 < 0.01
B16-F1 1.52 ± 0.02 2.50 ± 0.2, a= 3 2.99 ± 0.09, a= 6 0.57 0.20 0.23 < 0.01 < 0.01
PC-3 1.04 ± 0.03 3.17 ± 0.5, a= 12 3.14 ± 0.19, a= 6 > 0.99 < 0.01 < 0.01 < 0.01 < 0.01
MCF-7 0.96 ± 0.04 4.57 ± 1.1, a= 6 4.52 ± 0.9, a= 6 0.77 < 0.01 < 0.22 < 0.01 < 0.01
B16-F0 1.05 ± 0.02 3.36 ± 1.3, a= 6 3.69 ± 0.09, a= 3 > 0.99 < 0.01 < 0.01 < 0.01 < 0.01
The ﬁrst column shows exponent α values obtained from mean square displacement vs. time plots shown in Fig. 2c. Other columns show values for μ exponent – both from power law and truncated
power law ﬁts – calculated using the maximum likelihood estimates (MLEs), as described in detail in Supplementary Note 1/Supplementary Methods, and Akaike weights (wAIC) for all model
comparisons. Parameter a is the lower cutoff parameter determined using reweighted Kolmogorov–Smirnov (KS) statistic as described in56 (see also Supplementary Methods for more details). The 95%
conﬁdence intervals (CIs) are shown for all values. For all cell types, truncated power law (TP), power law (P), log-normal (LN), stretched exponential (SE), and exponential (E) distributions were
compared. Strongest supported model is highlighted in bold. wAIC comparisons were performed using lower cutoff values a (see Supplementary Tables 1 and 2) that are speciﬁed for the truncated power
law. Cumulative frequency distributions (CFDs, shown in Fig. 2d–f) for metastatic cells (PC-3M, MDA-MB-231, B16-F1) ﬁt best the truncated power law with 2 < μ < 3 consistent with Lévy walks (see
Supplementary Figure 5 and Supplementary Methods for details on all model comparisons); non-metastatic cells (PC-3, MCF-7, B16-F0) ﬁt best truncated power law with μ > 3 consistent with diffusive
motion. See Supplementary Movies 1–6. Analyses were based on the following numbers of cells and time points: MDA-MB-231 (n= 69 cells, m= 17,569 time points); MCF-7 (n= 15, m= 4,468); PC-3M
(n= 18, m= 4,833); PC-3 (n= 17, m= 5,457); B16-F1 (n= 53, m= 14,640); B16-F0 (n= 62, m= 18,585)
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Fig. 2 Superdiffusive and Lévy walks of metastatic cancer cells on linear microtracks. a Typical trajectories/displacement versus time of highly metastatic
cells (here for MDA-MB-231) feature characteristic small steps interspersed with unidirectional, long excursions. b In contrast, trajectories of non-
metastatic cells (here for MCF-7) are more random/”jiggly”. Ten representative trajectories per cell type are shown. The starting points for trajectories are
randomly positioned along the y axis (“Distance”) for clarity. See also Supplementary Movies 1–6 and 13–15 and Supplementary Figure 1 for trajectories for
PC-3, PC-3M, B16-F0, and B16-F1 cells and Supplementary Figure 2 for long-term trajectories. c Differences in the two modes of motility are quantiﬁed in
the log–log plots of the cells’ mean square displacement (in μm2) versus time, x2
  / tα. The values of α close to unity (PC-3: α= 1.04, 95% conﬁdence
interval ± 0.03; MCF-7: α= 0.96 ± 0.04; B16F0: α= 1.05 ± 0.02) indicate diffusive walks of non-metastatic cells. Metastatic cells are superdiffusive (PC-
3M: α= 1.58 ± 0.02; MD-MB-231: α= 1.54 ± 0.01; B16F1: α= 1.52 ± 0.02). d–f The cumulative frequency distributions, CFDs, of persistence times (t) for all
types of cells studied on microtracks. Markers are experimental statistics: magneta triangles for PC-3, red crosses for PC-3M, blue crosses for MDA-MB-
231, orange rectangles for MCF-7, green circles for B16-F0, and black circles for B16-F1. Solid lines are theoretical truncated power law ﬁts. Statistical
analysis of cancer cell movements on 1D microtracks is shown in Table 1
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and 2 and Supplementary Methods for all additional details on
model ﬁtting and comparisons). All data sets for metastatic cells
pass the goodness-of-ﬁt test performed according to the method
detailed in ref. 56 (Supplementary Note 3 and Supplementary
Figure 7). In this context, it is important to note that truncated
power law (with µ ~1–3) has become increasingly favored (over
pure power law) as a more relevant model for describing
bounded/limited biological systems and—similar to a pure power
law—is considered Lévy walk14,16–18. We also note that (i)
“walks” rather than “ﬂights”15 terminology is appropriate since,
as we veriﬁed, our migrating cells exhibit strong correlation
between persistence times and persistence lengths (i.e., step sizes);
and (ii) observing Lévy-like patterns in a simple 1D system in the
absence of chemoattractant gradients suggests that they may be
an inherent characteristic of metastatic cells.
Regarding non-metastatic cells, their CFDs also ﬁt best to a
truncated power law, but the exponents μ in these ﬁts are greater
than 3 (Fig. 2d–f and Table 1), which is in line with the purely
diffusive34,47 nature of these cells’ motions.
Lévy walks of metastatic cancer cells in live tumors. While the
microtracks offer a convenient platform for collecting large
numbers of motility data, these ex vivo results are not necessarily
indicative of in vivo motility patterns, which may be inﬂuenced by
local chemotactic gradients and/or cell interactions with the tissue
microenvironment. Extension to in vivo, however, is technically
challenging36,61 and further complicated in our case where
resolving individual cells over long (hours) times is necessary for
the collection of statistics ample enough to construct reliable
probability distributions. Also, it should be remembered that
in vivo analyses cannot offer complete correspondence with all the
cell types studied on microtracks and are limited to tumors (i)
lying within the penetration depth of the existing high-resolution
microscopy modalities (max. 600 μm in mouse dermis), and (ii)
for which appropriate animal protocols have been validated and
approved. In our study, the additional requirement to compare
metastatic versus non-metastatic cells of the same origin limited
the available choices to a pair of non-metastatic B16-F0 and
metastatic B16-F10 mouse melanoma cells. The trajectories of
these cells invading the mouse dermis were recorded using a
dorsal skin-fold chamber model43. Using combined near-infrared
and infrared multiphoton microscopy43, second-harmonic gen-
eration (SHG) allowed for the reconstruction of ﬁbrillar collagen
and myoﬁbers, while ﬂuorescence enabled visualization of blood
vessels and tracking of moving cell nuclei (Fig. 3).
On one hand, both B16-F0 and B16-F10 cells predominantly
formed invasion strands consisting of up to 100 individual cells
which jointly inﬁltrated the dermis by following linear tissue
interfaces provided by parallel perimuscular and perineural
microtracks, blood vessels, or collagen bundles (Fig. 3). On the
other hand, the path organization and kinetics of cell motions
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Fig. 3 Structure of the linear invasion strands in vivo. a Live B16-F0 (non-
metastatic) and B16-F10 (metastatic) tumors in mouse skin imaged with
epiﬂuorescence microscopy (cell nuclei marked with Histone-2B/mCherry,
green). Images are representative of least six tumors from at least three
independent mice per group. Insets show ﬁnger-like invasion strands
moving away from the main tumor mass. Scale bar is 100 μm. b Enlarged
images corresponding to the tips of the invasion strands. Few (~2–4) B16-
F10 cells, so-called tip cells, detached from the invasion strands and
exhibited trajectories that over limited observation time appeared ballistic
(see also Fig. 4b, Zone 5). These tip cells were observed only in the very
outer zone 5 which was not included in Lévy walk analysis because of small
number of cells in this zone. Scale bar is 100 μm. Quantiﬁcation of (c)
tumor growth (quantiﬁcation based on tumor volume and expressed as an
increase over volume measured on day 1; time, days) and (d) invasion
strand length on day 6. Invasion strands were statistically longer in
metastatic tumors (average ~400 μm in B16-F10 vs. ~100 μm in B16-F0, red
horizontal lines). Error bars in c are standard deviations based on≥ 30
invasion strands from at least six tumors of three individual mice. e The
widths of invasion strands near the base (i.e., beginning of strand at tumor’s
edge), center between base and tip, and the tip region (recorded on day 6;
error bars give standard deviations of ≥7 invasion strands from at least four
tumors of three individual mice). f Individualized (with separation above
two nuclear diameters) versus compact cell positioning in leading tips of
invasion strands
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were markedly different for the non-metastatic (Fig. 4a and
Supplementary Movie 7) and metastatic cells (Fig. 4b and
Supplementary Movie 8). To quantify these motions, we divided
the entire tumor/strand domain into 150-μm wide zones with
zone 1 near the border of the tumor mass and incremental
outward numbering along the invasion zone (see Fig. 4a, b and
Table 2). The path organizations were found to be strongly zone-
dependent. At the tumor margin (zone 1), where cells are
“crowded” and frequent cell–cell collisions occur, the motions of
both B16-F0 and B16-F10 cells are “jiggly” and purely diffusive, as
evidenced by the “diffusion exponent” α ~ 1 (Fig. 4c). Beyond the
tumor border, within zone 2, the cells experience more frequent
collisions from one side (zone 1) and are effectively “pushed
away” from the tumor exhibiting slightly differing degrees of
superdiffusive motions (α ~ 1.38 for B16-F0 and α ~ 1.63 for B16-
F10). The differences between the inherent characteristics of cell
motions—i.e., not dominated by crowding effects/cell–cell colli-
sions—manifest themselves fully in zones 3 and 4, with non-
metastatic cells reverting to diffusive motions (α ~ 1) while
metastatic cells remaining evidently superdiffusive, with α ~
1.47–1.87. These characteristics were conserved over the entire
time domain (i.e., not only short term as in correlated/persistent
random walks) and were statistically signiﬁcant as evidenced by
the 95% conﬁdence intervals for α listed in Table 2.
Most importantly, the cumulative frequency distributions,
CFDs, of persistence times shown in Fig. 4d reveal that non-
metastatic B16-F0 cells move diffusively (truncated power law
with μ > 3), whereas the metastatic B16-F10 cells have a CFD
characteristic of a Lévy walk (truncated power law with 2 < μ < 3).
For the B16-F0 cells, the Akaike weights quantifying the
appropriateness of the ﬁts show that even though truncated
power law ﬁt is preferred over pure power law or exponential ﬁts,
μ > 3 indicates diffusive motion for all zones. For B16-F10 cells,
truncated power law ﬁt is also appropriate in all zones with
Akaike weights close to 1, but the value of exponent 2 < μ < 3 for
zones 2–4 indicates Lévy-like motion (Table 2). When analyzing
all data for B16-F10 from zones 2–4 together, µ ~ 2.36 ± 0.13 with
Akaike weights for truncated power law close to 1. Overall, these
in vivo studies resemble the results obtained for cell’s on
microtracks both in terms of the diffusive-vs-Lévy dichotomy
and the linearity of cell trajectories (here, along tissue micro-
channels rather than microtracks). We note that additional
analysis of cells migrating through 3D collagen gels (to probe the
effects of 1D vs. 3D microenvironment) are also consistent with
diffusive-vs-Lévy motions for normal versus cancer cells (see
Supplementary Note 4 and Supplementary Figures 8, 9).
“Reprogramming” Lévy walks into other types of motions.
Assuming that the Lévy-type walks might be an untoward char-
acteristic of “predatory” metastatic cells, we next focused on the
question whether these walks could somehow be altered—in
particular—could they be reverted into diffusive motions char-
acterizing the non-invasive cancer cells?
To this end, we inhibited—either chemically or by using
speciﬁc siRNAs—selected proteins known to be involved in
polymerization of actin ﬁlaments and their organization into
higher-order structures and known to drive extension of cellular
protrusions62. Results summarized in Fig. 5 and Table 3 (see also
Supplementary Movies 9–12 and 16–18) for the metastatic MDA-
MB-231 cells moving on the microtracks reveal that inhibiting
Rac1 (with chemical inhibitor NSC23766) or knocking down of
Coﬁlin-1 (involved in actin ﬁlament depolymerization), Proﬁlin-1
(regulating actin polymerization), or Dia-1 (involved in poly-
merization of unbranched actin ﬁlaments) increased μ exponents
slightly, but not as much as to fully eliminate Lévy-like motions,
(Table 3, see also Supplementary Figures 10–13). In contrast,
inhibition of the Arp2/3 (but not of upstream GTPase Rac1,
Fig. 5b and Supplementary Movie 11)— involved in the
polymerization of actin into dendritic/branched networks at cell’s
“front”—by a small-molecule inhibitor CK666 not only slowed
the metastatic cells down, from 0.99 μm/min to 0.57 μm/min, but
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Fig. 4 Migration of non-metastatic and metastatic cells from live tumors in
mouse skin. a, b Cell movements within invasion strands formed by up to
100 tumor cells and relation to the guidance structures of the tumor
microenvironment, observed by using high-resolution multiphoton
microscopy (see Supplementary Movies 7 and 8 for trajectories). The
snapshots from these movies are shown for (a) B16-F0 and (b) B16-F10
tumors. AlexaFluor 750-labeled dextran was used to visualize blood vessels
(red), Histone-2B/mCherry marks the nuclei of cells (green), and ﬁbrillar
collagen was revealed by SHG (second-harmonic generation; blue). Dashed
yellow lines divide the invasion strands into ﬁve zones, each 150-μm wide.
Scale bar is 150 μm. c The values of the “diffusion exponents” α indicate
that both B16-F0 and B16-F10 cells are diffusive at the tumor margin (zone
1, α~1) and superdiffusive (zone 2, α~1.4–1.6) with entering the invasion
zone. Away from the tumor (zones 3–4), however, the metastatic cells
remain superdiffusive while the non-metastatic ones show diffusive
behavior. Error bars correspond to 95% conﬁdence intervals. d The
cumulative frequency distributions, CFDs, of persistence times are
truncated power law with μ > 3 for diffusive B16-F0 (blue crosses, Zones
1–3) and truncated power law with μ~2.36 for B16-F10 (red circles, Zones
2–4) performing Lévy walks. Markers are experimental statistics for
persistence times. Solid lines are truncated power law ﬁts. Statistical
analysis of cancer cell movements in vivo is shown in Table 2
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changed the nature of their motions from Lévy-like to diffusive
(Fig. 5d, Supplementary Figure 14, Supplementary Movies 9, 17,
and Supplementary Table 4 for the summary of all speed data).
When Myosin II—typically involved in forming contractile actin
networks and bundles and causing concurrent cell rear retrac-
tion62—was inhibited by blebbistatin at intermediate inhibitor
concentrations (see Fig. 5 legend), the cell speed changed only
slightly from 0.99 μm/min to 1.13 μm/min, but caused cells to
move ballistically (i.e., steadily in one direction; note that in the
context of this work, “ballistic” corresponds to motions for which
persistence times are longer than total observation time and for
which α ~2; Fig. 5c and Supplementary Movie 10). In addition,
pronounced changes in the motility patterns could also be
achieved by inhibition of several proteins simultaneously. A case
in point here is the reversal of Lévy to diffusive walks by the
simultaneous inhibition of Myosin II with 10 μM of blebbistatin
and of Rac-1 with 100 μM of NSC23766 (Supplementary
Figures 11 and 13, Supplementary Movies 12 and 18)—what is
interesting about this result is that the inhibition of each of the
proteins separately (cf. Fig. 5b, c) does not lead to diffusive
walking, implying a synergistic/cooperative action of the two
proteins in controlling the Lévy-walk movement pattern.
The role of protrusion-retraction synchronization in Lévy
walks. Our previous morphodynamic proﬁling analyses have
shown that in metastatic cells, the protrusions and retractions are
highly “synchronized” both in space and in time; in contrast,
protrusions and retractions formed by non-metastatic cells are
not “synchronized”63. In order to test if such protrusion-
retraction synchronization can give rise to truncated Lévy walk/
power law step-size distributions, we developed a simple model
described in detail in Supplementary Note 5, Supplementary
Figures 15 and 16. Brieﬂy, we considered a scenario in which the
probabilities of taking left-right steps depend on prior history
(non-Markovian process). We showed that if consecutive
steps slightly favor moves in the “same” direction – e.g., as
observed in the microscale dynamics of cell membrane where
persistence of membrane protrusion typically depends on levels
of actin regulators, such as Rac1 and Arp2/3, activation of
the positive feedback loops, precise spatiotemporal regulation of
Rho family GTPases, and coupling of protrusion to substrate
adhesion2,62—then the overall distribution of persistence length
can follow truncated power law (Supplementary Figures 15 and
16). The general conclusion of this modeling effort is, therefore,
that synchronization (or desynchronization) of front-back
protrusions/retractions may determine the overall motility pat-
tern. The model indicates that cells in which front and back
dynamics are synchronized are expected to perform truncated
Lévy walks (as in our experiments with metastatic cells) whereas
lack of synchronization should translate into diffusive motion (as
in non-metastatic cells and metastatic cells treated with inhibi-
tors). Experimentally, we observe some signatures of “desyn-
chronization” of front-rear protrusion-retractions in MDA-MB-
231 cells treated with inhibitors (or their combination) that revert
Lévy to diffusive motion (see Supplementary Figure 14 for details
and Supplementary Movies 16–18). Based on these results, we
propose a hypothesis that Lévy-like movement pattern in meta-
static cancer cells on 1D microtracks results from the balance/
competition of persistent protrusion—via synchronized front-
rear motions dependent on Arp2/3—and an effective myosin II-
dependent mechanism for switching the direction of cell motion.
Discussion
Taken together, the above results establish the presence of Lévy-
like movement patterns in a range of metastatic cancer cells, and
also suggest means of changing this motility phenotype. Meta-
static cells not only move “faster and more persistently”10 than
their non-metastatic counterparts, but while doing so, also display
a fundamentally distinct path structure. This “predatory” navi-
gation strategy is independent of external chemotactic signals as
gradients of various chemokines, EGF, or VEGF are all absent in
the microtrack experiments. This work contributes to the growing
body of knowledge indicating that Lévy-like movement
patterns are present and fundamentally important not only for
humans26,27 and multicellular animals17–25, but also on
cellular6,28,29 and subcellular levels16.
Lévy walk movement patterns are generally different from and
should not be confused with classical models of cell motions such
as persistent and simple correlated random walks (PRW/CRW
reviewed by1). The latter are generally characterized by ballistic
(i.e., persistent in direction) motions at short time and diffusive at
long time scales. In contrast, Lévy walks are superdiffusive over
long times thus allowing the searcher to move farther away from
the starting point in a shorter time than CRW/PRW strategy
would. This being said, it should be noted that recent theoretical
analyses and experimental evidence from multicellular animal
movements indicate that related movement patterns, speciﬁcally
multi-phasic walks (e.g., composite CRWs and composite
Brownian walks), in which the mover switches between two or
more kinds of simple walk patterns (mathematically characterized
Table 2 Statistical analysis of cancer cell movements in vivo
Cell type MSD (α) MLE for μ Akaike weights
Truncated power law TP P E
B16-F0
Zone 1 1.03 ± 0.04 3.58 ± 0.24 0.77 0.22 < 0.01
Zone 2 1.38 ± 0.04 3.57 ± 0.21 0.57 0.42 < 0.01
Zone 3 0.99 ± 0.04 3.85 ± 0.35 0.59 0.40 < 0.01
Zone 4 – – – – –
B16-F10
Zone 1 1.07 ± 0.07 4.97 ± 0.55 0.58 0.41 < 0.01
Zone 2 1.63 ± 0.06 2.34 ± 0.21 0.90 0.09 < 0.01
Zone 3 1.47 ± 0.05 2.66 ± 0.26 0.93 0.06 < 0.01
Zone 4 1.87 ± 0.05 2.03 ± 0.22 0.99 < 0.01 < 0.01
TP truncated power law, P power law, E exponential distribution
Table summarizes exponent α values and the maximum likelihood estimates, MLEs70, of the truncated power law exponents μ for cancer cell movements in vivo for the data described in Fig. 3 and 4 (±
values give the 95% conﬁdence intervals). Lower cutoff value was a= 5min for all in vivo data sets. Away from the tumor, in zones 2–4, Akaike weights heavily favor truncated power law with 2 < μ < 3
(shown in bold) indicating Lévy walks for B16-F10. For B16F0 for all zones, distributions correspond to truncated power law with μ > 3 indicating diffusive walks. See Supplementary Movies 7 and 8.
Statistics were based on the following numbers of cells and time points − B16-F0, zone #1 (n= 59 cells, m= 2,925 data points); zone #2 (n= 57, m= 2,806); zone #3 (n= 28, m= 1,383). B16-F10, zone
#1 (n= 30 cells, m= 990 data points); zone #2 (n= 30, m= 990); zone #3 (n= 29, m= 957); zone #4 (n= 23, m= 759)
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by step-sizes from two or more exponential distributions which
can sum up to a power law distribution60) have been suggested
“to have parameters that are ﬁne-tuned to [optimal] Lévy
walk”17,59. While bi-phasic (or bi-modal) walks have realistic
physical correlates (such as run phases and reorientation/wait
phases)64, it seems difﬁcult to ﬁnd physical justiﬁcation for
ﬁtting/using more complex multi-exponential distributions
to describe step-size distributions, such as the ones we observe
here for metastatic cells. In addition, discrete nature of cell
motility data we collected precluded reliable ﬁtting of bi-
exponential distributions (see Supplementary Note 2 for more
information).
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Fig. 5 Altering the motility strategy of metastatic cancer cells. Examples of typical cell trajectories: Lévy walking (control MDA-MB-231 cells, a or with Rac1
inhibited, b), ballistic (Myosin II inhibited, c) diffusive (Arp2/3 inhibited, d). Line width= 20 μm, same for all three images. In displacement plots, ten
representative trajectories for each treatment are shown. Quantiﬁcation of motility characteristics (exponents μ, α along with the ± 95% conﬁdence
intervals) for MDA-MD-231 cells moving on microtracks and having individual actin-binding proteins inhibited is summarized in Table 3. e Log–log plots of
the cells’ mean square displacement versus time, x2
  ¼ tα. The slopes correspond to exponents α; note that inhibition of Arp2/3 with CK666 results in
diffusive motion, α ~ 1, while inhibition of Myosin II results in ballistic motion, α~2. f The corresponding cumulative frequency distributions, CFDs, of
persistence times. Markers are experimental statistics for persistence times. Solid lines are truncated power law ﬁts with respective μ values shown in
Table 3. For the chemical inhibitors data shown corresponds to: 40 μM CK666 (for Arp2/3, yellow crosses), 100 μM NSC23755 (Rac1, green triangles),
10 μM Blebbistatin (Myosin II, red rectangles), and control (black circles). The additional results for all drug and siRNA concentrations tested are shown in
Supplementary Figures 10–13. See Supplementary Movies 9–12 and 16–18
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While our observations of Lévy walk motility pattern for
metastatic cells moving through very simple experimental
environments in the absence of chemotactic gradients suggest
that Lévy walk is an intrinsic property of metastatic cancer cells,
current work does not exclude the possibility that constrained
complex geometries, such as aligned collagen ﬁbers and linear
micro-tunnels/tracks, contribute to the emergence of the Lévy
walk pattern in complex in vivo environments. In this context,
it is interesting that recent theoretical studies have shown that
linear constraints, such as one-dimensional micro-channels,
provide one of the simplest systems for the emergence of
optimal Lévy walks23,32. For example, in the system described
by Reynolds et al.23, a Lévy-like displacement patterns (so-
called Weierstrassian Lévy walk23,29) can emerge as a result of
the moving object bouncing chaotically off the walls of the
channel. While intriguing, such minimalistic mechanical
explanation might not be at work in our 1D microtrack system
simply because there are no “walls”, and cellular motions are
determined mostly by cell–substrate adhesive interactions and
are gently guided by adhesive micropatterns. At the same time,
cellular interactions with complex geometric/mechanical con-
straints could play role in wider micro-channels/tracks, such as
in PDMS micro-channels used by others65 and in vivo
settings36,43.
To the best of our knowledge, the work presented here is the
ﬁrst demonstration of Lévy-like movement patterns in adherent
mammalian cells, as well as in the context of metastatic cancer.
Regarding the latter aspect, we ponder whether adopting
the Lévy-like modality of migration might endow metastatic
cells with a successful strategy for dispersing and searching for
suitable loci where to seed new metastases. The prevailing
theory (though disputed by others,34) stipulates that Lévy walk
searches are considered to be optimal within a narrow range of
circumstances30–33. Speciﬁcally, non-destructive Lévy walk
searches with μ~ 2 were considered optimal provided that
targets are randomly distributed and scarce and searcher does
not have prior knowledge about the target locations30–32.
However, more recent theoretical work has shown that Lévy
walk searches (again, with μ~ 2) are optimal under much
broader environmental conditions than previously thought and
that Lévy searchers experience fewer long periods of starvation
(compared with exponential, composite Brownian and ballistic
searchers)33,66. Furthermore, the so-called adaptive Lévy
searching (where searcher has some knowledge of the target
distribution and, upon target detection, responds by switching
from extensive Lévy searching to intensive Brownian searching)
has been shown to outperform adaptive ballistic and composite
Brownian searches67. Interestingly, the theoretical 2D path
structure analysis33,34 highlights a remarkable difference in
movement patterns between Lévy (with μ ~ 2.5, close to values
observed in some of our experiments) and exponential
searchers. The former takes many small steps in a focused area
resulting in thorough focused exploration (high oversampling)
until one large step takes it to another area (similar to 1D path
structure of our metastatic cells, see Supplementary Movies 13–
15). In contrast, an exponential searcher diffuses more gradu-
ally and covers the area more evenly without a thorough
exploration of any particular spots33. This otherwise sub-
optimal Lévy searcher (μ~ 2.5) performs extremely well at
intermediate levels of prey/target abundance. In the context of
metastasis, focused local exploration characteristic of Lévy walk
(with μ~ 2.5) may be useful for ﬁnding “hot spots” of defective
basement membranes68 followed by ballistic motions along
linear collagen ﬁbers and/or micro-channels toward another set
of basement membranes before entering the bloodstream.
Interestingly, risk of predation—condition relevant to meta-
static cancer cells which during dissemination in vivo are
constantly targeted by immune cells—alters optimal search
strategy such that searchers executing Lévy walk with 2 < μ < 3
have higher ﬁtness than those with μ ≤ 269. Taken together, our
work suggests that Lévy-like movements represent an emergent
strategy of how highly motile metastatic cells move within
complex microenvironments, and because such movement
patterns could be advantageous, they may be maintained and/or
ﬁne-tuned by selection pressures.
Naturally, the present results should be generalized to as many
types of cells/cancers and conditions (for example, micro-channels)
as possible, though especially the in vivo studies are currently
limited by the inability to visualize tumors lying deeper into the
animal and to obtain long-enough trajectories. In addition, we do
not yet fully understand the origin of Lévy walks at the level of
cytoskeletal dynamics. While we have developed a simple model
(see Supplementary Note 5 and Supplementary Figures 15, 16)
that could ascribe these walks by the synchronization of
the cell’s “front” protrusion (driven by Arp2/3-mediated nucleation
of actin ﬁlaments) and “back” retraction (enabled by actomyosin
contraction), such assumptions need further scrutiny and experi-
mental validation. We see further effort in this area justiﬁed by the
hope that by eliminating the ability of metastatic cells to execute
“predatory” Lévy walks through the human body, it might be
possible to decrease the ability of these cells to seed metastatic
cancers.
Table 3 Statistical analysis of metastatic cancer cell movements upon inhibition of actin regulators
Protein MSD (α) MLE for μ Akaike weights
inhibited Truncated power law TP P E
Control 1.54 ± 0.01 2.49 ± 0.07 > 0.99 < 0.01 < 0.01
Coﬁlin1siRNA 1.56 ± 0.05 3.01 ± 0.14 > 0.99 < 0.01 < 0.01
Proﬁlin1siRNA 1.28 ± 0.01 2.62 ± 0.08 > 0.99 < 0.01 < 0.01
Dia1siRNA 1.51 ± 0.09 2.57 ± 0.11 > 0.99 < 0.01 < 0.01
Arp2/3CK666 1.01 ± 0.03 3.27 ± 0.09 > 0.99 < 0.01 < 0.01
Rac1NSC23766 1.51 ± 0.03 2.51 ± 0.08 > 0.99 < 0.01 < 0.01
Myosin II Blebbistatin 1.83 ± 0.09 1.76 ± 0.07 > 0.99 < 0.01 < 0.01
Table summarizes α exponent values and the maximum likelihood estimates, MLEs70, of the truncated power exponents μ for all treatments (± values give the 95% conﬁdence intervals) described in
Fig. 5. For the knockdowns, the values shown correspond to 30 nM siRNA concentrations. For the chemical inhibitors data shown corresponds to: 40 μM CK666 (for Arp2/3), 100 μM NSC23755 (Rac1),
10 μM Blebbistatin (Myosin II). The additional results for all drug and siRNA concentrations tested are shown in Supplementary Figures 10–14. Notice that Arp2/3 inhibition (highlighted in bold) reverts
motions to diffusive characterized by α ~ 1 and truncated power law distribution with μ > 3. Lower cutoff values were a= 6 for Control, Coﬁlin1, and Proﬁlin1 siRNAs, and a= 3 for other treatments. Note
that in all cases truncated power law (TP) distribution is favored over power law (P) and exponential (E) distributions, and diffusive-vs-Lévy characteristic is determined by the magnitude of the μ
exponent. Analyses based on the following numbers of cells and time points: Control (n= 69 cells, m= 17,569 time points); Coﬁlin1siRNA (n= 25 cells, m= 7,466 time points); Proﬁlin1 siRNA (n= 29 cells,
m= 7,250 time points); Dia1 siRNA (n= 7 cells, m= 2,017 time points); Arp2/3 CK666 (n= 36 cells, m= 9,008 time points); Rac1NSC (n= 26 cells, m= 7,407 time points); Myosin IIBlebbistatin (n= 26 cells,
m= 5,413 time points). See Supplementary Movies 9–12 and Supplementary Movies 16–18
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Methods
In vivo observation of cell trajectories. The movements of stable Histone2B/EGF
or Histone2B/mCherry expressing non-metastatic B16-F0 and metastatic B16-F10
mouse melanoma cells were observed in live tumors established in mouse
dermis by using the dorsal skin-fold chamber model43. Dorsal skin-fold chambers
were transplanted on a skin ﬂap of C57/B16 J mice (Charles River) and B16-F0 or
B16-F10 Histone2B-EGFP/mCherry cells were implanted by injection of 5 ×
104–2 × 105 cells into the dermis adjacent to the deep dermal vascular plexus. For
visualization of blood vessels, AlexaFluor 750-labeled 70 kD dextran was injected
intravenously (2 mg/mouse). A customized multiphoton microscope (TriMScope-
II, LaVisionBioTec) setup was used which allowed for simultaneous second-
harmonic generation (SHG) to reconstruct tissue interfaces, and ﬂuorescence
imaging to track blood vessels and the movements of B16-F0 and B16-F10
cells stably expressing Histone-2B/GFP in live mouse dermis. Time-lapse
acquisition was done 3–9 days after tumor cell implantation for 1–3 h at 5 or 10
min intervals.
All animal experiments were approved by the ethical committee on animal
experiments and performed in the Central Animal Laboratory of the Radboud
University, Nijmegen, in accordance with the Dutch Animal Experimentation Act
and the European FELASA protocol (www.felasa.eu/guidelines.php).
Tracking cell movements on 1D microtrack substrates. Tracks for cell loco-
motion were microetched in gold-on-glass substrates using the so-called Wet
Etching40,48,49 technique (see Fig. 1a) where unetched gold regions were protected
against cell adhesion with oligo(ethylene glycol)-terminated alkyl thiols, (HS(CH2)11
(OCH2CH2)6OH (ProChimia Surfaces, Gdansk, Poland: www.prochimia.com). PC-
3, PC3-M, MCF-7, MDA-MB-231, B16-F0 and B16-F1 cells were cultured according
to the American Type Culture Collection (ATCC) protocol or as described
previously40,48,49. Linear tracks were coated with Laminin (Sigma-Aldrich, cat.
#L2020) or Laminin 5 (LN 5; extracted from 804G cells in crude form as previously
described52). Cell migration was monitored on inverted microscope (TMD, Nikon)
equipped with phase-contrast optics (10 × , 0.25 NA objectives) and CCD camera
(Sensys, Photometrics, Tucson, AZ). Image acquisition was driven by Metamorph
software (Universal Imaging Corp., Worchester, PA). Time-lapse videos were col-
lected over 16 h in 3-min intervals. Cell positions were assigned by their center-of-
mass coordinates.
Data analysis. Heavy-tailed models and ﬁtting procedures: The equations used in
the comparisons of the heavy-tailed models can be found in Supplementary
Table 1. Power law and exponential distribution parameters were estimated using
analytical expression for maximum likelihood estimator, as discussed
elsewhere56,57. Parameters for truncated power law, log-normal, and stretched
exponential distributions were found using numerical maximum likelihood esti-
mation and veriﬁed by visual inspection of likelihood maps. The appearance of
largely negative μ values in case of log-normal model is demonstrated in Supple-
mentary Figure 6. Effectively, the log-normal curve is being stretched to better ﬁt
power law-like distribution of the data, suggesting that log-normal is not the
optimal model for the data. When using only positive μ, the resulting log-normal
likelihood and, therefore, wAIC are worse. The resulting parameters are shown in
the Supplementary Table 2. Parameter a is a lower cutoff parameter, the choice of
which is described below, and b is an upper cutoff parameter used in truncated
power law estimation, and corresponds to the maximal point in each dataset.
Lower cutoff estimation: To estimate the choice of the lower cutoff parameter a,
we used a technique based on reweighted Kolmogorov–Smirnov (rKS) statistic,
described in detail in ref. 56. In brief, the rKS is calculated for all a values taken
from the set of unique values of persistence times in each dataset. Then, a is chosen
where rKS is minimal and the number of remaining data points after thresholding
by a is not less than 50% of the original dataset. In cases of truncated and regular
power law, exponent values in Table 1 are shown for lower cutoffs determined
separately using rKS, whereas wAIC for all distributions are calculated using cutoff
values for the truncated power law.
For all other experimental details, please see Supplementary Methods/
Supplementary Notes 1–3 online.
Data and code availability
Data and code used to generate results in the current study are available from the
corresponding authors upon reasonable request.
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